The world’s biggest sporting event is coming to California. Could cannabis businesses, retailers, and investors benefit from a surge in tourism?

Retail portfolios, strategic acquisitions, real estate, and manufacturing are attracting increasing attention as cannabis enters a new phase.

The California cannabis industry may finally be entering a new phase. Here’s why consolidation, Schedule III, and capital markets matter.

California operators may now reposition medical cannabis licenses as Schedule III and FDA alignment reshape the market.

The intoxicating hemp ban could disrupt gummies, beverages, and vapes while strengthening regulated cannabis markets.

Cannabis Schedule 3 and 280E reform could drive M&A, boost valuations, and reshape cannabis real estate across the market.

Los Angeles retail rents are slowing, creating new risks and opportunities across cannabis real estate, leases, and M&A.

Cannabis M&A consolidation in California is accelerating as major players align production and distribution through strategic deals.

420 cannabis sales surge 2026 could be the most mainstream yet as consumer demand, vapes, and M&A trends converge.

New FDA and CMS developments may reshape cannabis M&A, business valuations, and real estate as federal regulation expands.

Smart money is moving into cannabis property for sale in California as the market shifts from distress to strategic consolidation and growth.

After years of distress, the California cannabis market may be approaching a turning point as consolidation accelerates and investors re-enter.

A stalled multi-million dollar expansion reveals the real cannabis business growth challenges behind rapid scale in cultivation and real estate.

Seller financing is common in cannabis deals, not by choice but by necessity. This analysis explores where these deals quietly go wrong after closing.

Cannabis vape sales have overtaken flower in California for the first time. The shift highlights durable consumer demand and growing M&A focus on manufacturing.

How Mid-Market Acquisitions Point to Broader Consolidation Ahead For much of the past several years, cannabis mergers and acquisitions have felt frozen in place. Capital markets were cautious, valuations faltered, and many buyers sat on the sidelines. But that appears to be changing. A series of recent deals — from strategic infrastructure buys to brand consolidations — suggests that cannabis M&A activity is beginning to heat up. While none of these deals are traditional “blo